After historic acquisition, Coloplast CEO takes stock: "Building up capacity will take a while"

The recent USD 2.5bn acquisition of Atos Medical has been in the works for many years, says President and CEO at Coloplast Kristian Villumsen. With its biggest acquisition ever now behind it, Coloplast is now putting a damper on its acquisition hunt.

Photo: Stine Bidstrup/ERH

Now that Coloplast has announced its acquisition of Swedish firm Atcos Medical, there are no more big company purchases in the works at the medtech firm.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs